(4 years, 5 months ago)
Written StatementsI hereby give notice of the Department for Business, Energy and Industrial Strategy’s intention to seek an advance from the contingencies fund totalling £3,360,000 to enable expenditure on the covid-19 vaccines programme to be spent ahead of the passage of the Supply and Appropriation Act.
The funding is urgently required for HM Government to secure manufacturing capability for a possible antibody treatment.
Parliamentary approval for additional resources of £3,360,000 for this new expenditure will be sought in a main estimate for the Department for Business, Energy and Industrial Strategy. Pending that approval, urgent expenditure estimated at £3,360,000 will be met by repayable cash advances from the contingencies fund.
The cash advances will be repaid upon receiving Royal Assent on the Supply and Appropriation Bill.
[HCWS354]